Abstracts

NSE and UCHL1 as Prognostic Biomarkers for Mortality From Cryptococcal Meningitis

Background: Despite new, more effective treatments, mortality due to HIV-associated cryptococcal meningitis remains high. Markers that are associated with mortality may be helpful to identify individuals who would benefit from intensive management and monitoring, and also improve understanding of underlying disease pathology. The neurological biomarkers Neuron specific enolase (NSE), Ubiquitin C-terminal hydrolase-L1 (UCHL1), and Glial…

One-Dose Efficacy of Long-Acting Injectable Diarylquinoline in Mouse Model of TB Preventive Therapy

Background: Use of long-acting injectables (LAIs) has the potential to simplify tuberculosis (TB) preventive therapy (TPT) addressing issues such as pill burden and adherence. Bedaquiline (BDQ) is a key drug in new short-course regimens for treatment of rifampin-resistant TB and could provide a short-course ‘pan’-TPT option for drug-susceptible and rifampin-resistant infections. BDQ and other diarylquinolines…

Outcomes of Adults With HIV Receiving TB Preventive Therapy in Kampala, Uganda

Background: After decades of underuse, tuberculosis preventive therapy (TPT) underwent rapid scale-up in Uganda in 2020 as part of a national campaign. This campaign overlapped with a pragmatic trial comparing the impact of TB screening strategies on TPT uptake among antiretroviral therapy (ART)-naïve adults that also included standardized protocols for assessing TPT eligibility and TPT-specific…

Viral Suppression Among Adults Receiving Dolutegravir-Based ART and 3-Months Isoniazid-Rifapentine

Background: Prior studies have reported conflicting results regarding the safety and/or effectiveness of rifapentine-based tuberculosis (TB) preventive therapy with dolutegravir (DTG)-based ART. In an interim analysis, we previously found that co-administration of 3HP (3 months weekly isoniazid+rifapentine) with TDF/3TC/DTG (TLD) was safe for adults initiating routine ART, but that those who received 3HP+TLD were less…

Testicular Safety of a Pretomanid Regimen (BPaMZ) in Men With Pulmonary Drug-Resistant Tuberculosis

Background: Testicular toxicity was observed in rodents exposed to high doses of pretomanid. Pretomanid is approved for use in treatment regimens for drug-resistant tuberculosis (DR-TB). This study evaluated the testicular safety of 26 weeks of pretomanid in adult males with DR-TB as part of a BPaMZ (bedaquiline, pretomanid, moxifloxacin, pyrazinamide) regimen. Methods: Twenty-six men with…

Decline in Time to Recovery From Mild-Moderate COVID-19 in a Large Platform Placebo-Controlled Trial

Background: Epidemiological data suggest that the duration of symptoms in patients with COVID-19 has decreased over the course of the pandemic. Robust estimates of the magnitude of change are not yet available. We estimated the change in time to recovery from COVID-19 among participants enrolled in the placebo arms of the Accelerating COVID-19 Therapeutic Interventions…

Association of Long COVID With Health-Related Quality-of-Life Outcomes

Background: Long COVID is a significant and growing public health burden. The association of long COVID with health-related quality-of-life (HrQOL) has not been well-characterized. Methods: Participants (N=546) who received blinded placebo in the ACTIV-2/A5401 outpatient COVID-19 treatment trial with symptom diary data at week 24 were assessed for long COVID, defined as presence of self-assessed…